L1CAM expression in endometrial carcinomas is regulated by usage of two different promoter regions

BMC Molecular Biology

Volumn 11, Issue , 2010, Pages

  Pfeifer, Marco ^a   Schirmer, Uwe ^a   Geismann, Claudia ^b   Schäfer, Heiner ^b   Sebens, Susanne ^b   Altevogt, Peter ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CELL ADHESION MOLECULE; CELL ADHESION MOLECULE L1; LYMPHOID ENHANCER FACTOR 1; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SNAIL; UNCLASSIFIED DRUG; MESSENGER RNA; NERVE CELL ADHESION MOLECULE L1; SNAIL FAMILY TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR;

ARTICLE; BINDING SITE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; EXON; GENE EXPRESSION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PROMOTER REGION; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION; TUMOR GROWTH; UPREGULATION; ANIMAL; ENDOMETRIUM TUMOR; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; TUMOR CELL LINE;

GASTROPODA;

ANIMALS; BASE SEQUENCE; BETA CATENIN; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; ENDOMETRIAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEURAL CELL ADHESION MOLECULE L1; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; TRANSCRIPTION FACTORS; TRANSCRIPTION INITIATION SITE;

EID: 77955942231     PISSN: None     EISSN: 14712199     Source Type: Journal    
DOI: 10.1186/1471-2199-11-64     Document Type: Article

References (33)

1. Thiery JP, Sleeman JP. Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 2006, 7(2):131-142. 10.1038/nrm1835, 16493418.
2. Gavert N, Ben-Ze'ev A. Epithelial-mesenchymal transition and the invasive potential of tumors. Trends Mol Med 2008, 14(5):199-209. 10.1016/j.molmed.2008.03.004, 18406208.
3. Brummendorf T, Kenwrick S, Rathjen FG. Neural cell recognition molecule L1: from cell biology to human hereditary brain malformations. Curr Opin Neurobiol 1998, 8(1):87-97. 10.1016/S0959-4388(98)80012-3, 9568396.
4. Schachner M. Neural recognition molecules and synaptic plasticity. Curr Opin Cell Biol 1997, 9(5):627-634. 10.1016/S0955-0674(97)80115-9, 9330865.
5. Thies A, Schachner M, Moll I, Berger J, Schulze HJ, Brunner G, Schumacher U. Overexpression of the cell adhesion molecule L1 is associated with metastasis in cutaneous malignant melanoma. Eur J Cancer 2002, 38(13):1708-1716. 10.1016/S0959-8049(02)00105-3, 12175686.
6. Kaifi JT, Reichelt U, Quaas A, Schurr PG, Wachowiak R, Yekebas EF, Strate T, Schneider C, Pantel K, Schachner M, et al. L1 is associated with micrometastatic spread and poor outcome in colorectal cancer. Mod Pathol 2007, 20(11):1183-1190. 10.1038/modpathol.3800955, 17873897.
7. Fogel M, Mechtersheimer S, Huszar M, Smirnov A, Abu DA, Tilgen W, Reichrath J, Georg T, Altevogt P, Gutwein P. L1 adhesion molecule (CD 171) in development and progression of human malignant melanoma. Cancer Lett 2003, 189(2):237-247. 10.1016/S0304-3835(02)00513-X, 12490317.
8. Li S, Jo YS, Lee JH, Min JK, Lee ES, Park T, Kim JM, Hong HJ. L1 cell adhesion molecule is a novel independent poor prognostic factor of extrahepatic cholangiocarcinoma. Clin Cancer Res 2009, 15(23):7345-7351. 10.1158/1078-0432.CCR-09-0959, 19920102.
9. Kodera Y, Nakanishi H, Ito S, Misawa K, Ito Y, Nakayama G, Koike M, Fujiwara M, Yamamura Y, Nakao A. Expression of L1 cell adhesion molecule is a significant prognostic factor in pT3-stage gastric cancer. Anticancer Res 2009, 29(10):4033-4039.
10. Mechtersheimer S, Gutwein P, Agmon LN, Stoeck A, Oleszewski M, Riedle S, Postina R, Fahrenholz F, Fogel M, Lemmon V, et al. Ectodomain shedding of L1 adhesion molecule promotes cell migration by autocrine binding to integrins. J Cell Biol 2001, 155(4):661-674. 10.1083/jcb.200101099, 2198870, 11706054.
11. Meier F, Busch S, Gast D, Goppert A, Altevogt P, Maczey E, Riedle S, Garbe C, Schittek B. The adhesion molecule L1 (CD171) promotes melanoma progression. Int J Cancer 2006, 119(3):549-555. 10.1002/ijc.21880, 16506207.
12. Gavert N, Conacci-Sorrell M, Gast D, Schneider A, Altevogt P, Brabletz T, Ben-Ze'ev A. L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers. J Cell Biol 2005, 168(4):633-642. 10.1083/jcb.200408051, 2171754, 15716380.
13. Silletti S, Yebra M, Perez B, Cirulli V, McMahon M, Montgomery AM. Extracellular signal-regulated kinase (ERK)-dependent gene expression contributes to L1 cell adhesion molecule-dependent motility and invasion. J Biol Chem 2004, 279(28):28880-28888. 10.1074/jbc.M404075200, 15128735.
14. Gavert N, Sheffer M, Raveh S, Spaderna S, Shtutman M, Brabletz T, Barany F, Paty P, Notterman D, Domany E, et al. Expression of L1-CAM and ADAM10 in human colon cancer cells induces metastasis. Cancer Res 2007, 67(16):7703-7712. 10.1158/0008-5472.CAN-07-0991, 17699774.
15. Gast D, Riedle S, Issa Y, Pfeifer M, Beckhove P, Sanderson MP, Arlt M, Moldenhauer G, Fogel M, Kruger A, et al. The cytoplasmic part of L1-CAM controls growth and gene expression in human tumors that is reversed by therapeutic antibodies. Oncogene 2008, 27(9):1281-1289. 10.1038/sj.onc.1210747, 17952127.
16. Sebens Muerkoster S, Werbing V, Sipos B, Debus MA, Witt M, Grossmann M, Leisner D, Kotteritzsch J, Kappes H, Kloppel G, et al. Drug-induced expression of the cellular adhesion molecule L1CAM confers anti-apoptotic protection and chemoresistance in pancreatic ductal adenocarcinoma cells. Oncogene 2007, 26(19):2759-2768. 10.1038/sj.onc.1210076, 17086212.
17. Stoeck A, Gast D, Sanderson MP, Issa Y, Gutwein P, Altevogt P. L1-CAM in a membrane-bound or soluble form augments protection from apoptosis in ovarian carcinoma cells. Gynecol Oncol 2007, 104(2):461-469. 10.1016/j.ygyno.2006.08.038, 17030349.
18. Djabali M, Mattei MG, Nguyen C, Roux D, Demengeot J, Denizot F, Moos M, Schachner M, Goridis C, Jordan BR. The gene encoding L1, a neural adhesion molecule of the immunoglobulin family, is located on the X chromosome in mouse and man. Genomics 1990, 7(4):587-593. 10.1016/0888-7543(90)90203-7, 2387585.
19. Chapman VM, Keitz BT, Stephenson DA, Mullins LJ, Moos M, Schachner M. Linkage of a gene for neural cell adhesion molecule, L1 (CamL1) to the Rsvp region of the mouse X chromosome. Genomics 1990, 8(1):113-118. 10.1016/0888-7543(90)90232-J, 1964443.
20. Kohl A, Giese KP, Mohajeri MH, Montag D, Moos M, Schachner M. Analysis of promoter activity and 5' genomic structure of the neural cell adhesion molecule L1. J Neurosci Res 1992, 32(2):167-177. 10.1002/jnr.490320206, 1404492.
21. Kallunki P, Edelman GM, Jones FS. Tissue-specific expression of the L1 cell adhesion molecule is modulated by the neural restrictive silencer element. J Cell Biol 1997, 138(6):1343-1354. 10.1083/jcb.138.6.1343, 2132545, 9298989.
22. Gast D, Riedle S, Schabath H, Schlich S, Schneider A, Issa Y, Stoeck A, Fogel M, Joumaa S, Wenger T, et al. L1 augments cell migration and tumor growth but not beta3 integrin expression in ovarian carcinomas. Int J Cancer 2005, 115(4):658-665. 10.1002/ijc.20869, 15704102.
23. Raveh S, Gavert N, Ben-Ze'ev A. L1 cell adhesion molecule (L1CAM) in invasive tumors. Cancer Lett 2009, 282(2):137-145. 10.1016/j.canlet.2008.12.021, 19144458.
24. Huszar M, Pfeifer M, Schirmer U, Kiefel H, Konecny GE, Ben-Arie A, Edler L, Munch M, Muller-Holzner E, Jerabek-Klestil S, et al. Up-regulation of L1CAM is linked to loss of hormone receptors and E-cadherin in aggressive subtypes of endometrial carcinomas. J Pathol 2010, 220(5):551-561. 10.1002/path.2673, 20077528.
25. Brabletz T, Jung A, Hermann K, Gunther K, Hohenberger W, Kirchner T. Nuclear overexpression of the oncoprotein beta-catenin in colorectal cancer is localized predominantly at the invasion front. Pathol Res Pract 1998, 194(10):701-704.
26. Geismann C, Morscheck M, Koch D, Bergmann F, Ungefroren H, Arlt A, Tsao MS, Bachem MG, Altevogt P, Sipos B, et al. Up-regulation of L1CAM in pancreatic duct cells is transforming growth factor beta1- and slug-dependent: role in malignant transformation of pancreatic cancer. Cancer Res 2009, 69(10):4517-4526. 10.1158/0008-5472.CAN-08-3493, 19435915.
27. Konecny GE, Venkatesan N, Yang G, Dering J, Ginther C, Finn R, Rahmeh M, Fejzo MS, Toft D, Jiang SW, et al. Activity of lapatinib a novel HER2 and EGFR dual kinase inhibitor in human endometrial cancer cells. Br J Cancer 2008, 98(6):1076-1084. 10.1038/sj.bjc.6604278, 2275492, 18334972.
28. Corcoran DL, Feingold E, Benos PV. FOOTER: a web tool for finding mammalian DNA regulatory regions using phylogenetic footprinting. Nucleic Acids Res 2005, (33 Web Server):W442-446. 10.1093/nar/gki420, 1160181, 15980508.
29. Vallin J, Thuret R, Giacomello E, Faraldo MM, Thiery JP, Broders F. Cloning and characterization of three Xenopus slug promoters reveal direct regulation by Lef/beta-catenin signaling. J Biol Chem 2001, 276(32):30350-30358. 10.1074/jbc.M103167200, 11402039.
30. Conacci-Sorrell M, Simcha I, Ben-Yedidia T, Blechman J, Savagner P, Ben-Ze'ev A. Autoregulation of E-cadherin expression by cadherin-cadherin interactions: the roles of beta-catenin signaling, Slug, and MAPK. J Cell Biol 2003, 163(4):847-857. 10.1083/jcb.200308162, 2173691, 14623871.
31. Bolos V, Peinado H, Perez-Moreno MA, Fraga MF, Esteller M, Cano A. The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors. J Cell Sci 2003, 116(Pt 3):499-511. 10.1242/jcs.00224, 12508111.
32. Kato K, Maesawa C, Itabashi T, Fujisawa K, Otsuka K, Kanno S, Tada H, Tatemichi Y, Kotani K, Oikawa H, et al. DNA hypomethylation at the CpG island is involved in aberrant expression of the L1 cell adhesion molecule gene in colorectal cancer. Int J Oncol 2009, 35(3):467-476.
33. Kuwajima A, Iwashita J, Murata J, Abe T. The histone deacetylase inhibitor butyrate inhibits melanoma cell invasion of Matrigel. Anticancer Res 2007, 27(6B):4163-4169.